Global X Fds genomic biotech shares owned by Blue Bell Private Wealth Management
Quarter-by-quarter ownership of Global X Fds genomic biotech (GNOM) shares owned by Blue Bell Private Wealth Management
from 13F filings
Historical chart of Blue Bell Private Wealth Management investment in Global X Fds genomic biotech
Tip: Access up to 7 years of quarterly data
All positions including Global X Fds genomic biotech held by Blue Bell Private Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Global X Fds genomic biotech by Blue Bell Private Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $842 | 74 | 11.38 |
| 2023-12-31 | $855 | 74 | 11.55 |
| 2023-09-30 | $753 | 74 | 10.18 |
| 2023-06-30 | $896 | 74 | 12.12 |
| 2023-03-31 | $911 | 74 | 12.32 |
| 2022-12-31 | $935 | 74 | 12.65 |
| 2022-09-30 | $2.0k | 164 | 12.20 |
| 2022-06-30 | $2.0k | 164 | 12.20 |
| 2022-03-31 | $8.0k | 504 | 15.87 |
| 2021-12-31 | $10k | 504 | 19.84 |
More positions owned by Blue Bell Private Wealth Management
View all positions for Blue Bell Private Wealth Management